将从中国引进?巨头战略转型进行时:飙ADC引擎,炸抗病毒困局

生物药大时代
19 Jun

▲8月1-2日2025生物医药创新博览会扫码报名注:本文不构成任何投资意见和建议,以官方/公司公告为准;本文仅作医疗健康相关药物介绍,非治疗方案推荐(若涉及),不代表平台立场。任何文章转载需得到授权。三十多年来,吉利德作为全球生物制药领域的领军企业,自成立就以抗病毒药物研发为核心,逐步拓展至肿瘤治疗、肝病、抗炎等领域。以下是截止2025年第一季度公司研发管线情况:肿瘤治疗领域:CAR-T为核心,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10